Article Details
Retrieved on: 2020-12-29 17:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Shares of Aprea Therapeutics Inc (NASDAQ: APRE) have received a target price decrease from $34 to $6 from Morgan Stanley. These are the details.
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here